Annual Total Liabilities
$321.09 M
+$131.19 M+69.09%
December 31, 2023
Summary
- As of February 7, 2025, STRO annual total liabilities is $321.09 million, with the most recent change of +$131.19 million (+69.09%) on December 31, 2023.
- During the last 3 years, STRO annual total liabilities has risen by +$259.02 million (+417.36%).
- STRO annual total liabilities is now at all-time high.
Performance
STRO Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$340.61 M
+$3.75 M+1.11%
September 30, 2024
Summary
- As of February 7, 2025, STRO quarterly total liabilities is $340.61 million, with the most recent change of +$3.75 million (+1.11%) on September 30, 2024.
- Over the past year, STRO quarterly total liabilities has increased by +$19.52 million (+6.08%).
- STRO quarterly total liabilities is now at all-time high.
Performance
STRO Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
STRO Total Liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +69.1% | +6.1% |
3 y3 years | +417.4% | +6.1% |
5 y5 years | +250.5% | +6.1% |
STRO Total Liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +261.4% | at high | +308.9% |
5 y | 5-year | at high | +448.1% | at high | +565.4% |
alltime | all time | at high | +448.1% | at high | +565.4% |
Sutro Biopharma Total Liabilities History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $340.61 M(+1.1%) |
Jun 2024 | - | $336.87 M(+10.3%) |
Mar 2024 | - | $305.38 M(-4.9%) |
Dec 2023 | $321.09 M(+69.1%) | $321.09 M(+0.5%) |
Sep 2023 | - | $319.39 M(+3.0%) |
Jun 2023 | - | $310.18 M(+79.7%) |
Mar 2023 | - | $172.60 M(-9.1%) |
Dec 2022 | $189.90 M(+113.7%) | $189.90 M(+11.1%) |
Sep 2022 | - | $170.97 M(-3.2%) |
Jun 2022 | - | $176.56 M(+112.0%) |
Mar 2022 | - | $83.30 M(-6.2%) |
Dec 2021 | $88.84 M | $88.84 M(+1.1%) |
Sep 2021 | - | $87.89 M(+68.1%) |
Jun 2021 | - | $52.29 M(+2.1%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2021 | - | $51.19 M(-17.5%) |
Dec 2020 | $62.06 M(+5.9%) | $62.06 M(-1.7%) |
Sep 2020 | - | $63.12 M(-10.8%) |
Jun 2020 | - | $70.78 M(-1.4%) |
Mar 2020 | - | $71.79 M(+22.5%) |
Dec 2019 | $58.58 M(-36.0%) | $58.58 M(-5.2%) |
Sep 2019 | - | $61.77 M(-10.8%) |
Jun 2019 | - | $69.26 M(-3.5%) |
Mar 2019 | - | $71.74 M(-21.7%) |
Dec 2018 | $91.60 M(-38.8%) | $91.60 M(-68.0%) |
Sep 2018 | - | $286.46 M(+61.7%) |
Jun 2018 | - | $177.20 M(+18.3%) |
Dec 2017 | $149.77 M(-6.5%) | $149.77 M |
Dec 2016 | $160.18 M | - |
FAQ
- What is Sutro Biopharma annual total liabilities?
- What is the all time high annual total liabilities for Sutro Biopharma?
- What is Sutro Biopharma annual total liabilities year-on-year change?
- What is Sutro Biopharma quarterly total liabilities?
- What is the all time high quarterly total liabilities for Sutro Biopharma?
- What is Sutro Biopharma quarterly total liabilities year-on-year change?
What is Sutro Biopharma annual total liabilities?
The current annual total liabilities of STRO is $321.09 M
What is the all time high annual total liabilities for Sutro Biopharma?
Sutro Biopharma all-time high annual total liabilities is $321.09 M
What is Sutro Biopharma annual total liabilities year-on-year change?
Over the past year, STRO annual total liabilities has changed by +$131.19 M (+69.09%)
What is Sutro Biopharma quarterly total liabilities?
The current quarterly total liabilities of STRO is $340.61 M
What is the all time high quarterly total liabilities for Sutro Biopharma?
Sutro Biopharma all-time high quarterly total liabilities is $340.61 M
What is Sutro Biopharma quarterly total liabilities year-on-year change?
Over the past year, STRO quarterly total liabilities has changed by +$19.52 M (+6.08%)